The Mechanism of Lymphatic Access of Two Cholesteryl Ester Transfer Protein Inhibitors (CP524,515 and CP532,623) and Evaluation of Their Impact on Lymph Lipoprotein Profiles

Author： Trevaskis Natalie   Shanker Ravi   Charman William   Porter Christopher  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.27, Iss.9, 2010-09, pp. : 1949-1964

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cholesteryl ester transfer protein inhibitors

By Shinkai H.  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 5, 2001-05 ,pp. : 739-745

Informa Healthcare

Access to resources Recommend Favorite

Raising high-density lipoprotein cholesterol with inhibitors of cholesteryl ester transfer protein – a new approach to coronary artery disease

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 10, 2004-10 ,pp. : 1365-1368

Informa Healthcare

Access to resources Recommend Favorite

Cholesteryl Ester Transfer Protein (CETP) Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 5, 2009-04 ,pp. : 419-427

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of cholesteryl ester transfer protein – a new approach to coronary artery disease

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 2, 2006-02 ,pp. : 99-106

Informa Healthcare

Access to resources Recommend Favorite

Dalcetrapib, a cholesteryl ester transfer protein modulator

By Hooper Amanda J   Burnett John R  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 9, 2012-09 ,pp. : 1427-1432

Informa Healthcare

Access to resources Recommend Favorite